Cadazolid vs Vancomycin for Treatment of Clostridioides difficile Infection: Systematic Review with Meta-Analysis.

CONCLUSION: Cadazolid is non-inferior to vancomycin and offers a promising alternative for the treatment of CDI.
PMID: 31376824 [PubMed - as supplied by publisher]

Source: Current Clinical Pharmacology - August 1, 2019 Category: Drugs & Pharmacology Authors: Aziz M, Simcha W, Fatima R, Rajani S, Eid A, Nawras A Tags: Curr Clin Pharmacol Source Type: research